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An efficient synthesis of (4-aryl-3-methyl-4,5-dihydropyrazolo[3,4-c]pyrazol-1(3aH)-yl)(3-hydroxyquinoxalin-2-yl) 
methanones is described via reactions of ethyl acetoacetate with 3-hydroxyquinoxaline-2-carbohydrazide. The structures of 
the compounds prepared have been determined by spectral analyses. 
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Pyrazoles are an important class of heterocyclic 
compounds. Literature reports reveal that many 
synthetic pyrazole derivatives are used in the 
pharmaceutical, agrochemical, photographic and other 
fields. Examples of such synthetic pyrazole derivatives 
are Sildenafil (Viagra)1, Ionazlac2 and Difenamizole3. 
The synthesis of pyrazole derivatives has been well 
explored using the so-called [3+2] atom fragments, 
where β-diketones or α,β-unsaturated ketones are used 
as the 3-atom building block and hydrazines as the 2-
atom fragment. In the last decade, our research group 
has reported the general synthesis of 1,1,1-trihalo-4-
alkoxy-3-alken-2-ones, 3-atom building blocks, and 
demonstrated their usefulness in heterocyclic 
preparations4. In addition, 1,1,1-trichloro-4-alkoxy3-
alken-2-ones have been found to be powerful 
precursors for the synthesis of carboxyl derivative 
heterocycles, as the trichloromethyl group undergoes 
a hydrolysis reaction when treated with either 
alcohols, sulfuric acid (96%) or their mixture in 
water5. However, the use of unsymmetrically 
substituted precursors often leads to a mixture of 
regioisomers hindering the use of this method for 
regiospecifically obtaining the carboxyalkylpyrazole 
derivatives by a one-pot procedure6. 
In addition, the pyrazole derivatives have many 
applications on crop protection chemistry. There were 
many herbicidally, fungicidally and insecticidally 
active pyrazole classes. So pyrazole derivatives have 
attracted much attention of chemists. In continuation 
of earlier work7-10 and as part of our research 
program, we were interested in obtaining compounds 
endowed with anti-inflammatory, antipyretic and 
mainly analgesic activity. Our contributions in this 
field include the investigation of novel pyrazole 
derivatives and their docking studies. 
 
Results and Discussion 
 
Chemistry 
3-Hydroxyquinoxaline-2-carbohydrazide and ethyl 
acetoacetate reacts to form 1-(3-hydroxyquinoxaline-
2-carbonyl)-3-methyl-1H-pyrazol-5(4H)-one 2 which 
on condensation with aromatic aldehydes gives 4-
arylidene-1-(3-hydroxyquinoxaline-2-carbonyl)-3-
methyl-1H-pyrazol-5(4H)-one 3a-f. Compounds 3a-f 
are cyclised by reacting with hydrazine hydrate to 








Antimicrobial assay by well diffusion method 
The antimicrobial assay was carried out by the well 
diffusion method (Desta, 2005) S.aureus, E.coli, 
Klebsiella pneumonia, Salmonella paratyphi A and 
Salmonella paratyphi B. A standardized 1 to  
2 × 107 cfu/mL 0.5 McFarland standards was introduced 
on to the surface of sterile agar plate and evenly 
distributed the inoculums by using a sterile glass 
spreader. Simultaneously 8 mm wells were cut from the 
plate using a sterile cork borer. 60 µL of the pigment at 
10 mg/mL was introduced in to each well. The agar 
plates were incubated aerobically at 37°C. After 24 h the 
inhibition zones were measured with a ruler and 
compared with the control well containing only DMSO 
and 10 mg/mL of streptomycin as standard. The results 
of each compound are shown in Table I. 
Control inhibition zone (which indicates inhibition 
zone of solvent) was subtracted from inhibition zone 




All the synthesized compounds were screened  
for their anti-bacterial activity against gram-positive 
bacteria i.e., S. aureus, E. coli, Klebsiella pneumonia, 
Salmonella paratyphi A and Salmonella paratyphi B. 
at 100mg/mL concentration (Figure 1). The compounds 
possessing chlorophenyl, fluorophenyl groups as 




The protein 1jff (tubulin) was downloaded from 
RSC PDB and was docked. Compound 4a was the 
most efficient for inhibiting the structural protein 
followed by the compound 4. Least inhibiton was 
seen by the compound 5. The major amino acids 
which were involved in the binding of the compounds 
were tyrosine, asparagines, alanine, glutamine, 




Thin layer chromatography was run on silica gel-G 
and visualization were done using UV light or iodine. 
Melting points are uncorrected and were determined 
in open capillary tubes in sulphuric acid bath. IR 
spectra were recorded by Perkin-Elmer 1000 
Table I — Antimicrobial activity of compounds VI to X 
Compd Inhibition zone (in mm) against microorganism 
S.aureus E.coli Klebsiella pneumoniae Salmonella paratyphi A Salmonella paratyphi B 
a 5 6 4 − 2 
b 12 8 12 6 10 
c 8 10 8 8 9 
d 4 8 5 6 8 
e 3 6 2 5 9 
f − 4 1 − 2 




Figure 1 — Inhibition zone in mm 




instrument in KBr pellets. 1H NMR spectra were 
recorded with a Varian Mercury Plus 400 MHz 
instrument in DMSO-d6 solvent using 
tetramethylsilane as internal standard. Jeol-JMS D-




A mixture of hydrazide (10 mmol) and ethyl 
acetoacetate (10 mmol) in EtOH(10 mL) was refluxed 
for 36 h, cooled and the reaction mixture was poured 
onto ice-water to give a powder which was crystallized 
from ethanol/acetic acid. 1H NMR (DMSO-d6,  
400 MHz):  9.78 (brs, 1H), 8.09 (d, 2H), 7.60 (t, 2H), 




Hydrazide compound (0.001 mol) was dissolved in 
10mL acetic acid, arylaldehyde (0.001 mol) and 
anhydrous sodium acetate (0.001 mol) were also 
added to it. The resulting solution was refluxed for 
12 h, cooled, filtered, poured onto crushed ice and 
kept for some time. Product is gradually separated is 
filtered and dried. 
4-Benzylidene-1-(3-hydroxyquinoxaline-2-carbonyl)-
3-methyl-1H-pyrazol-5(4H)-one, 3a: 1H NMR 
(DMSO-d6, 400 MHz):  9.42 (brs, 1H), 8.01 (d, 2H), 
7.64 (d, 2H), 7.27 (m, 5H), 7.01 (s, 1H), 2.21 (S, 3H); 
13C NMR (DMSO-d6, 100 MHz):  168.1, 164.2, 
162.0, 157.6, 151.9, 149.2, 145.3, 142.0, 139.7, 136.1, 




1H NMR (DMSO-d6, 400 MHz):  9.41 (brs, 1H), 8.01 
(d, 2H), 7.64 (d, 2H), 7.48 (m, 2H), 7.22 (d, 2H), 7.01 (s, 
1H), 2.21 (S, 3H); MS: m/z 393 (M+H)+, 394 (M+2H)+. 
Table II — Interaction Table 





























































































































































1H NMR (DMSO-d6, 400 MHz):  9.40 (brs, 1H), 
8.03 (d, 2H), 7.65 (d, 2H), 7.49 (m, 2H), 7.21 (d, 2H), 




1H NMR (DMSO-d6, 400 MHz):  9.42 (brs, 1H), 8.02  
(d, 2H), 7.66 (d, 2H), 7.50 (m, 2H), 7.22 (m, 2H), 7.03 
(s, 1H), 2.20 (S, 3H); MS: m/z 377 (M+H)+. 
4-(2-Fluorobenzylidene)-1-(3-hydroxyquinoxaline-
2-carbonyl)-3-methyl-1H-pyrazol-5(4H)-one, 3e: 
1H NMR (DMSO-d6, 400 MHz):  9.50 (brs, 1H), 
8.01 (d, 2H), 7.65 (d, 2H), 7.49 (m, 2H),  






1H NMR (DMSO-d6, 400 MHz):  9.66 (brs, 1H), 
8.05 (d, 2H), 7.66 (d, 2H), 7.38 (s, 1H), 7.28 (t, 2H), 
7.13 (m, 1H), 7.01 (s, 1H), 2.31 (s, 3H), 2.20 (S, 3H); 




Above compound (0.001 mol) and hydrazine 
hydrate (0.001 mol) were taken into dry ethanol (10 mL) 
and a few drops of acetic acid added. It was then 
refluxed for 9-10 h, concentrated, cooled and poured 
on crushed ice. The product obtained was washed 
several time with water and dried. 
(3-Hydroxyquinoxalin-2-yl)(3-methyl-4-phenyl-4, 
5-dihydropyrazolo[3,4-c]pyrazol-1(3aH)-yl)methanone, 
4a: 1H NMR (DMSO-d6, 400 MHz):  9.78 (brs, 1H), 
8.04 (d, 2H), 7.62 (t, 2H), 7.40 (m, 3H), 7.18 (d, 2H), 
6.83 (brs, 1H), 4.02 (d, 1H), 2.64 (d, 1H), 2.22  
(S, 3H); 13C NMR (DMSO-d6, 100 MHz):  170.1, 
166.0, 156.01, 154.2, 148.1, 144.2, 142.0, 137.2, 
137.0, 133.6, 130.1, 127.9, 124.8, 124.6, 46.2, 44.1, 















methanone, 4b: 1H NMR (DMSO-d6, 400 MHz):  
9.77 (brs, 1H), 8.05 (d, 2H), 7.60 (t, 2H), 7.40 (d, 2H), 
7.18 (d, 2H), 6.82 (brs, 1H), 4.02 (d, 1H), 2.62 




methanone, 4c: 1H NMR (DMSO-d6, 400 MHz):  
9.75 (brs, 1H), 8.06 (d, 2H), 7.60 (m, 2H), 7.39 (d, 2H), 
7.19 (d, 2H), 6.80 (brs, 1H), 4.03 (d, 1H), 2.63  




methanone, 4d: 1H NMR (DMSO-d6, 400 MHz):  
9.78 (brs, 1H), 8.10 (d, 2H), 7.63 (m, 2H), 7.40 (m, 2H), 
7.20 (m, 2H), 6.82 (brs, 1H), 4.04 (d, 1H), 2.64  
(d, 1H), 2.21 (S, 3H); MS: m/z 391 (M+H)+. 
(4-(2-Fluorophenyl)-3-methyl-4,5-dihydropyrazolo 
[3,4-c]pyrazol-1(3aH)-yl)(3-hydroxyquinoxalin-2-yl) 
methanone, 4e: 1H NMR (DMSO-d6, 400 MHz):  
9.77 (brs, 1H), 8.11 (d, 2H), 7.64 (m, 2H), 7.41  
(m, 2H), 7.21 (m, 2H), 6.81 (brs, 1H), 4.03 (d, 1H), 
2.65 (d, 1H), 2.20 (S, 3H); MS: m/z 391 (M+H)+. 
(4-(4-Methylphenyl)-3-methyl-4,5-dihydropyrazolo 
[3,4-c]pyrazol-1(3aH)-yl)(3-hydroxyquinoxalin-2-yl) 
methanone, 4f: 1H NMR (DMSO-d6, 400 MHz):  
9.70 (brs, 1H), 8.10 (d, 2H), 7.68 (m, 2H), 7.38 (d, 2H), 
7.27 (s, 1H), 7.20 (m, 1H), 6.80 (brs, 1H), 4.01 (d, 1H), 
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